TABLE 5.
Base case results.
Result | Olaparib | Placebo | ICER |
---|---|---|---|
China | |||
QALY | 13.99 | 5.22 | 8.77 |
Total cost of regimen, $ | 61,477 | 2,773 | 58,704 |
ICER $/QALY | 6,694 | ||
The United States | |||
QALY | 13.99 | 5.22 | 8.77 |
Total cost of regimen, $ | 208,504 | 91,623 | 116,881 |
ICER $/QALY | 13,327 |
Abbreviations: ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life year.